FBXO32 and hepatocellular carcinoma: Upregulated FBXO32 promotes ubiquitin–proteasome degradation of pleckstrin homology domain leucine‐rich repeat protein phosphatase 2 (PHLPP2) through direct interactions, accordingly activating PI3K–AKT pathway and subsequently promoting HCC progression.